News
Bayer gets first approval for stroke drug asundexian
Bayer's oral Factor XIa inhibitor asundexian has been cleared in its first market, China, for secindary stroke prevention.
News
US Treasury proposes curbs on Chinese biotech deals
China has emerged as a major source of drug candidates for pharma groups, but a new proposal by the US Treasury could slam the brakes on future deals.
News
Five AI tools to spot prostate cancer backed for NHS use
NICE has backed temporary NHS use of five AI tools that can help detect prostate cancer on MRI scans, while more evidence on their value is gathered.
News
AZ grabs FDA nod for Ultomiris in rare kidney disease IgAN
AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.
News
Despite US policy changes, drug prices stay stubbornly high
US policy changes designed to curb drug prices seem ineffective, as the annual cost of new medicines still exceeds $250,000, curbing patient access.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
